S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
Log in
NASDAQ:CRSP

CRISPR Therapeutics News Headlines

$114.65
-0.84 (-0.73 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$100.00
Now: $114.65
$116.06
50-Day Range
$115.49
MA: $162.11
$210.04
52-Week Range
$32.30
Now: $114.65
$220.20
Volume5.23 million shs
Average Volume2.55 million shs
Market Capitalization$8.65 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.37

Headlines

CRISPR Therapeutics (NASDAQ CRSP) News Headlines Today

Source:
SourceHeadline
CRISPR Therapeutics (NASDAQ:CRSP) Stock Rating Reaffirmed by BarclaysCRISPR Therapeutics (NASDAQ:CRSP) Stock Rating Reaffirmed by Barclays
marketbeat.com - March 1 at 12:15 AM
3 Groundbreaking Genomics Stocks to Buy Now3 Groundbreaking Genomics Stocks to Buy Now
marketbeat.com - January 8 at 6:58 PM
3 Biotech Stocks to Watch in December (CRSP)3 Biotech Stocks to Watch in December (CRSP)
marketbeat.com - December 1 at 5:22 PM
Is CRISPR Stock Heading to $160 in 2021?Is CRISPR Stock Heading to $160 in 2021?
finance.yahoo.com - March 4 at 5:53 PM
CRISPR Therapeutics (NASDAQ:CRSP) Now Covered by Analysts at JMP SecuritiesCRISPR Therapeutics (NASDAQ:CRSP) Now Covered by Analysts at JMP Securities
americanbankingnews.com - March 4 at 2:01 PM
Anthem, BioMarin, CRISPR, GE and More Thursday Afternoon Analyst CallsAnthem, BioMarin, CRISPR, GE and More Thursday Afternoon Analyst Calls
247wallst.com - March 4 at 12:52 PM
CRISPR Therapeutics (NASDAQ:CRSP)  Shares Down 8.2% CRISPR Therapeutics (NASDAQ:CRSP) Shares Down 8.2%
americanbankingnews.com - March 3 at 8:26 PM
Barclays Boosts CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $140.00Barclays Boosts CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $140.00
americanbankingnews.com - March 1 at 8:33 AM
CRISPR Therapeutics (NASDAQ:CRSP) Rating Reiterated by BarclaysCRISPR Therapeutics (NASDAQ:CRSP) Rating Reiterated by Barclays
americanbankingnews.com - March 1 at 12:50 AM
CRISPR Therapeutics: Roadblock AheadCRISPR Therapeutics: Roadblock Ahead
seekingalpha.com - February 25 at 3:17 PM
CRISPR Therapeutics (NASDAQ:CRSP) Trading Down 7%CRISPR Therapeutics (NASDAQ:CRSP) Trading Down 7%
americanbankingnews.com - February 22 at 9:20 PM
Q1 2021 EPS Estimates for CRISPR Therapeutics AG (NASDAQ:CRSP) Decreased by AnalystQ1 2021 EPS Estimates for CRISPR Therapeutics AG (NASDAQ:CRSP) Decreased by Analyst
americanbankingnews.com - February 21 at 1:42 AM
Q1 2021 Earnings Estimate for CRISPR Therapeutics AG Issued By William Blair (NASDAQ:CRSP)Q1 2021 Earnings Estimate for CRISPR Therapeutics AG Issued By William Blair (NASDAQ:CRSP)
americanbankingnews.com - February 21 at 1:42 AM
Q1 2021 EPS Estimates for CRISPR Therapeutics AG (NASDAQ:CRSP) Lowered by Truist SecuritiQ1 2021 EPS Estimates for CRISPR Therapeutics AG (NASDAQ:CRSP) Lowered by Truist Securiti
americanbankingnews.com - February 19 at 7:22 AM
Q1 2021 EPS Estimates for CRISPR Therapeutics AG Reduced by Analyst (NASDAQ:CRSP)Q1 2021 EPS Estimates for CRISPR Therapeutics AG Reduced by Analyst (NASDAQ:CRSP)
americanbankingnews.com - February 19 at 7:22 AM
The Goldman Sachs Group Cuts CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $189.00The Goldman Sachs Group Cuts CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $189.00
americanbankingnews.com - February 17 at 6:00 PM
Wall Street Looks Again at Bluebird, Rivals, After Gene-Therapy SetbackWall Street Looks Again at Bluebird, Rivals, After Gene-Therapy Setback
finance.yahoo.com - February 17 at 9:05 AM
CRISPR Therapeutics (NASDAQ:CRSP) Price Target Raised to $187.00 at OppenheimerCRISPR Therapeutics (NASDAQ:CRSP) Price Target Raised to $187.00 at Oppenheimer
americanbankingnews.com - February 17 at 9:02 AM
Chardan Capital Boosts CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $175.00Chardan Capital Boosts CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $175.00
americanbankingnews.com - February 17 at 9:02 AM
Interesting CRSP Put And Call Options For April 1stInteresting CRSP Put And Call Options For April 1st
nasdaq.com - February 11 at 4:10 PM
Bear of the Day: CRISPR Therapeutics (CRSP)Bear of the Day: CRISPR Therapeutics (CRSP)
finance.yahoo.com - February 11 at 11:09 AM
Meridian Bioscience, CRISPR Therapeutics, Tilray and Uber highlighted as Zacks Bull and Bear of the DayMeridian Bioscience, CRISPR Therapeutics, Tilray and Uber highlighted as Zacks Bull and Bear of the Day
finance.yahoo.com - February 11 at 11:09 AM
CRISPR Therapeutics to Participate in the Guggenheim Healthcare Talks 2021 Oncology DayCRISPR Therapeutics to Participate in the Guggenheim Healthcare Talks 2021 Oncology Day
finance.yahoo.com - February 5 at 10:24 AM
CRISPR (CRSP) to Report Q4 Earnings: Whats in the Cards?CRISPR (CRSP) to Report Q4 Earnings: What's in the Cards?
finance.yahoo.com - February 5 at 10:24 AM
CRSP Feb 2021 155.000 callCRSP Feb 2021 155.000 call
au.finance.yahoo.com - February 2 at 5:54 PM
CRSP Jul 2021 75.000 putCRSP Jul 2021 75.000 put
au.finance.yahoo.com - February 2 at 5:54 PM
Vertex Stock Dips On Mixed Report; Investors Eye Its Next CatalystsVertex Stock Dips On Mixed Report; Investors Eye Its Next Catalysts
finance.yahoo.com - February 1 at 7:56 PM
CRISPR Therapeutics Announces the Appointment of Philippe Drouet as Chief Commercial OfficerCRISPR Therapeutics Announces the Appointment of Philippe Drouet as Chief Commercial Officer
finance.yahoo.com - February 1 at 9:55 AM
CRSP Jan 2022 310.000 callCRSP Jan 2022 310.000 call
uk.finance.yahoo.com - January 23 at 2:21 PM
CRSP Jan 2021 177.500 putCRSP Jan 2021 177.500 put
uk.finance.yahoo.com - January 23 at 2:21 PM
The Zacks Analyst Blog Highlights: Intellia Therapeutics, Editas Medicine, Fate Therapeutic, CRISPR Therapeutics and Vertex PharmaceuticalsThe Zacks Analyst Blog Highlights: Intellia Therapeutics, Editas Medicine, Fate Therapeutic, CRISPR Therapeutics and Vertex Pharmaceuticals
finance.yahoo.com - January 11 at 11:26 AM
3 Top Biotech Stocks To Put On Your January 2021 Watchlist3 Top Biotech Stocks To Put On Your January 2021 Watchlist
nasdaq.com - January 8 at 7:31 PM
Genetics Stocks Pop After Intellia Offers Update For Gene-Editing DrugsGenetics Stocks Pop After Intellia Offers Update For Gene-Editing Drugs
finance.yahoo.com - January 7 at 3:00 PM
3 Biotech Technological Developments to Watch Out For in 20213 Biotech Technological Developments to Watch Out For in 2021
finance.yahoo.com - January 7 at 9:54 AM
CRISPR Therapeutics Is Still Looking StrongCRISPR Therapeutics Is Still Looking Strong
finance.yahoo.com - January 6 at 6:48 PM
Thinking about trading options or stock in Crispr Therapeutics, GameStop, Moderna, Tesla, or FuelCell Energy?Thinking about trading options or stock in Crispr Therapeutics, GameStop, Moderna, Tesla, or FuelCell Energy?
marketwatch.com - December 29 at 7:47 PM
Interesting CRSP Put And Call Options For February 2021Interesting CRSP Put And Call Options For February 2021
nasdaq.com - December 24 at 2:30 PM
Intellia Therapeutics: The Smallest Of The Big 3 CRISPR Companies Has Big PotentialIntellia Therapeutics: The Smallest Of The Big 3 CRISPR Companies Has Big Potential
seekingalpha.com - December 23 at 1:37 PM
Cutting Edge CRISPR Therapeutics Has Cut a Path HigherCutting Edge CRISPR Therapeutics Has Cut a Path Higher
finance.yahoo.com - December 22 at 5:06 PM
Return On Capital Employed Overview: CRISPR TherapeuticsReturn On Capital Employed Overview: CRISPR Therapeutics
benzinga.com - December 22 at 12:06 PM
5 Medical Outperformers That Might Lose Steam in 20215 Medical Outperformers That Might Lose Steam in 2021
finance.yahoo.com - December 22 at 12:06 PM
First Week of CRSP February 2021 Options TradingFirst Week of CRSP February 2021 Options Trading
nasdaq.com - December 21 at 12:56 PM
Genetics Stocks Ablaze: Editas, Crispr, Intellia Rocket; Uniqure DivesGenetics Stocks Ablaze: Editas, Crispr, Intellia Rocket; Uniqure Dives
finance.yahoo.com - December 21 at 12:56 PM
Up 140% YTD, is CRISPR Therapeutics Still a Buy?Up 140% YTD, is CRISPR Therapeutics Still a Buy?
stocknews.com - December 18 at 10:14 AM
Megatrends To Invest In Now: 3 Best ETF PicksMegatrends To Invest In Now: 3 Best ETF Picks
finance.yahoo.com - December 16 at 2:28 PM
Growth Investors: Industry Analysts Just Upgraded Their CRISPR Therapeutics AG (NASDAQ:CRSP) Revenue Forecasts By 10%Growth Investors: Industry Analysts Just Upgraded Their CRISPR Therapeutics AG (NASDAQ:CRSP) Revenue Forecasts By 10%
nasdaq.com - December 16 at 9:27 AM
Where Will CRISPR Therapeutics Be in 10 Years?Where Will CRISPR Therapeutics Be in 10 Years?
finance.yahoo.com - December 15 at 8:53 AM
CRISPR Therapeutics Receives Grant to Advance In Vivo CRISPR/Cas9 Gene Editing Therapies for HIVCRISPR Therapeutics Receives Grant to Advance In Vivo CRISPR/Cas9 Gene Editing Therapies for HIV
finance.yahoo.com - December 14 at 12:52 PM
Crispr Therapeutics Deserves Attention After Positive CRISPR/Cas9 Patient DataCrispr Therapeutics Deserves Attention After Positive CRISPR/Cas9 Patient Data
seekingalpha.com - December 11 at 12:28 PM
CRISPR Therapeutics AG (CRSP) Phase 1/2 CTX001 Investor Update (Transcript)CRISPR Therapeutics AG (CRSP) Phase 1/2 CTX001 Investor Update (Transcript)
seekingalpha.com - December 11 at 2:25 AM
Are Options Traders Betting on a Big Move in CRISPR Therapeutics (CRSP) Stock?Are Options Traders Betting on a Big Move in CRISPR Therapeutics (CRSP) Stock?
finance.yahoo.com - December 8 at 4:38 PM
CRISPR Therapeutics and Vertex Present New Data for Investigational CRISPR/Cas9 Gene-Editing Therapy, CTX001™ at American Society of Hematology Annual Meeting and Exposition, Together With Publication in the New England Journal of MedicineCRISPR Therapeutics and Vertex Present New Data for Investigational CRISPR/Cas9 Gene-Editing Therapy, CTX001™ at American Society of Hematology Annual Meeting and Exposition, Together With Publication in the New England Journal of Medicine
finance.yahoo.com - December 5 at 4:00 PM
CRISPR Therapeutics AG (CRSP) CEO Samarth Kulkarni at Piper Sandler 32nd Annual Virtual Healthcare Conference (Transcript)CRISPR Therapeutics AG (CRSP) CEO Samarth Kulkarni at Piper Sandler 32nd Annual Virtual Healthcare Conference (Transcript)
seekingalpha.com - December 2 at 6:03 PM
This page was last updated on 3/6/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.